Reply to "Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A

Zhihua Li1, Anik Chaturbedi1, Shilpa Chakravartula1

  • 1Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

Abstract

No abstract available in PubMed .